Meds shortages: have your say
The Epilepsy Society has launched our official Medication Shortage Survey, alongside Epilepsy Action, SUDEP Action and Parkinson's UK. Have your say now!
Zach's Law: celebrating a great campaign
We had a truly remarkable celebration of our Zach’s Law campaign last week, with Zach meeting the Prime Minister, Rishi Sunak, and Leader of the Opposition, Sir Keir Starmer, and having photographs taken at 10 Downing Street.
Epilepsy Society welcomes redress scheme for valproate victims but says research is also vital
Today, Patient Safety Commissioner, Dr Henrietta Hughes, launched The Hughes Report calling for redress for all those harmed by valproate. The Epilepsy Society has warmly welcomed Dr Hughes' recommendations but warned that research into other epilepsy medications is also vital to stop history from repeating itself with other drugs.
MHRA resources give guidance around new restrictions on valproate prescribing
MHRA resources give guidance around new restrictions on valproate prescribing
Report exploring the impacts of some anti-seizure medicines in pregnancy attracts strong support at parliamentary launch
Report exploring the impacts of some anti-seizure medicines in pregnancy attracts strong support at parliamentary launch
We call for urgent investment in research as report puts lifetime cost of harm caused by epilepsy medications as high as £2.5m
A new report shows that the lifetime costs of harm caused by exposure to epilepsy medications during pregnancy could be as high as £2.5m. That is the cost for one child exposed to high-risk drugs during pregnancy and includes costs to the NHS, education and welfare systems, the affected individual, their family and wider society. The cost to the NHS alone is over half a million.